Click here to get full coverage on Dynamax Regice Max Monday: Event Guide - Pokémon GO Hub

Dynamax Regice Max Monday: Event Guide  Pokémon GO Hub

Dynamax Regice Max Monday: Event Guide - Pokémon GO Hub

Click here to get full coverage on Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co. - MarketBeat

Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co.  MarketBeat

Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co. - MarketBeat

Click here to get full coverage on Evan Van Dyn Hoven - Wisconsin Badgers

Evan Van Dyn Hoven - Wisconsin Badgers

Click here to get full coverage on DYN: Breakout year expected with DMD launch, DM1 progress, and eight clinical programs advancing - TradingView

DYN: Breakout year expected with DMD launch, DM1 progress, and eight clinical programs advancing  TradingView

DYN: Breakout year expected with DMD launch, DM1 progress, and eight clinical programs advancing - TradingView

Click here to get full coverage on Dyn divides in two to capture more of B2B market - MSN

Dyn divides in two to capture more of B2B market  MSN

Dyn divides in two to capture more of B2B market - MSN

Click here to get full coverage on Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs - Yahoo Finance

Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs  Yahoo Finance

Dyne Therapeutics (DYN) Shares Key Details For Pivotal. Drugs - Yahoo Finance

Click here to get full coverage on Insider Purchase: Director at $DYN Buys 2,000 Shares - Quiver Quantitative

Insider Purchase: Director at $DYN Buys 2,000 Shares  Quiver Quantitative

Insider Purchase: Director at $DYN Buys 2,000 Shares - Quiver Quantitative

Click here to get full coverage on Dyn spins off tech unit to commercialise sports streaming stack - SportsPro

Dyn spins off tech unit to commercialise sports streaming stack  SportsPro

Dyn spins off tech unit to commercialise sports streaming stack - SportsPro

Click here to get full coverage on Assessing Dyne Therapeutics (DYN) Valuation After Phase 3 HARMONIA Launch And New DELIVER Data - simplywall.st

Assessing Dyne Therapeutics (DYN) Valuation After Phase 3 HARMONIA Launch And New DELIVER Data  simplywall.st

Assessing Dyne Therapeutics (DYN) Valuation After Phase 3 HARMONIA Launch And New DELIVER Data - simplywall.st

Click here to get full coverage on J.P. Morgan Reaffirms Their Hold Rating on Dyne Therapeutics (DYN) - The Globe and Mail

J.P. Morgan Reaffirms Their Hold Rating on Dyne Therapeutics (DYN)  The Globe and Mail

J.P. Morgan Reaffirms Their Hold Rating on Dyne Therapeutics (DYN) - The Globe and Mail

Click here to get full coverage on Fund tied to Dyne Therapeutics (DYN) director sells stock - Stock Titan

Fund tied to Dyne Therapeutics (DYN) director sells stock  Stock Titan

Fund tied to Dyne Therapeutics (DYN) director sells stock - Stock Titan

Click here to get full coverage on Massillon Tigers football star Ja’Dyn Williams wins Art Teynor Award - Canton Repository

Massillon Tigers football star Ja’Dyn Williams wins Art Teynor Award  Canton Repository

Massillon Tigers football star Ja’Dyn Williams wins Art Teynor Award - Canton Repository

Click here to get full coverage on Dyne Therapeutics (NASDAQ:DYN) Trading 4.4% Higher - Here's Why - MarketBeat

Dyne Therapeutics (NASDAQ:DYN) Trading 4.4% Higher - Here's Why  MarketBeat

Dyne Therapeutics (NASDAQ:DYN) Trading 4.4% Higher - Here's Why - MarketBeat

Click here to get full coverage on Dyn takes sole rights to EHF club competitions through 2030 - MSN

Dyn takes sole rights to EHF club competitions through 2030  MSN

Dyn takes sole rights to EHF club competitions through 2030 - MSN

Click here to get full coverage on Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade - Yahoo Finance

Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade  Yahoo Finance

Dyne Therapeutics (DYN) Climbs 11.8% on Triple-Digit Price Target Upgrade - Yahoo Finance

Click here to get full coverage on Director buys 2,000 Dyne Therapeutics (DYN) shares in open market - Stock Titan

Director buys 2,000 Dyne Therapeutics (DYN) shares in open market  Stock Titan

Director buys 2,000 Dyne Therapeutics (DYN) shares in open market - Stock Titan

Click here to get full coverage on A Look At Dyne Therapeutics (DYN) Valuation After Q4 2025 Earnings Beat And Ongoing Clinical Progress - Yahoo Finance

A Look At Dyne Therapeutics (DYN) Valuation After Q4 2025 Earnings Beat And Ongoing Clinical Progress  Yahoo Finance

A Look At Dyne Therapeutics (DYN) Valuation After Q4 2025 Earnings Beat And Ongoing Clinical Progress - Yahoo Finance

Click here to get full coverage on Ja’Dyn Williams Receives Touchdown Club’s Hardnose Award - MassillonTigers.com

Ja’Dyn Williams Receives Touchdown Club’s Hardnose Award  MassillonTigers.com

Ja’Dyn Williams Receives Touchdown Club’s Hardnose Award - MassillonTigers.com

Click here to get full coverage on ForDyne B.V. (DYN) reports two Common stock dispositions on consecutive dates - Stock Titan

ForDyne B.V. (DYN) reports two Common stock dispositions on consecutive dates  Stock Titan

ForDyne B.V. (DYN) reports two Common stock dispositions on consecutive dates - Stock Titan

Click here to get full coverage on Director adds Dyne Therapeutics (DYN) shares in open-market purchase - Stock Titan

Director adds Dyne Therapeutics (DYN) shares in open-market purchase  Stock Titan

Director adds Dyne Therapeutics (DYN) shares in open-market purchase - Stock Titan

Click here to get full coverage on Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing - Yahoo Finance

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing  Yahoo Finance

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing - Yahoo Finance

Click here to get full coverage on Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN) - Seeking Alpha

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN)  Seeking Alpha

Dyne Therapeutics: Strong DELIVER Data Strengthens The Bull Case (NASDAQ:DYN) - Seeking Alpha

Click here to get full coverage on $DYN stock is up 12% today. Here's what we see in our data. | DYN Stock News - Quiver Quantitative

$DYN stock is up 12% today. Here's what we see in our data. | DYN Stock News  Quiver Quantitative

$DYN stock is up 12% today. Here's what we see in our data. | DYN Stock News - Quiver Quantitative

Click here to get full coverage on Ohio high school football video | Massillon head coach Nate Moore on LB Ja'Dyn Williams - Canton Repository

Ohio high school football video | Massillon head coach Nate Moore on LB Ja'Dyn Williams  Canton Repository

Ohio high school football video | Massillon head coach Nate Moore on LB Ja'Dyn Williams - Canton Repository

Click here to get full coverage on Dyne Therapeutics (DYN) Climbs 9.5% on Stellar Results for DMD Therapy Candidate - Yahoo Finance

Dyne Therapeutics (DYN) Climbs 9.5% on Stellar Results for DMD Therapy Candidate  Yahoo Finance

Dyne Therapeutics (DYN) Climbs 9.5% on Stellar Results for DMD Therapy Candidate - Yahoo Finance

Click here to get full coverage on Dyne Therapeutics eyes 2027 Duchenne drug launch, backed by $1.1B cash - Stock Titan

Dyne Therapeutics eyes 2027 Duchenne drug launch, backed by $1.1B cash  Stock Titan

Dyne Therapeutics eyes 2027 Duchenne drug launch, backed by $1.1B cash - Stock Titan

Click here to get full coverage on T. Rowe Price (NASDAQ: DYN) lists 26,578,437 shares, a 16.2% stake - Stock Titan

T. Rowe Price (NASDAQ: DYN) lists 26,578,437 shares, a 16.2% stake  Stock Titan

T. Rowe Price (NASDAQ: DYN) lists 26,578,437 shares, a 16.2% stake - Stock Titan

Click here to get full coverage on Biotech Dyne Therapeutics heads to three March investor conferences - Stock Titan

Biotech Dyne Therapeutics heads to three March investor conferences  Stock Titan

Biotech Dyne Therapeutics heads to three March investor conferences - Stock Titan

Click here to get full coverage on 688K Dyne Therapeutics (DYN) shares sold by ForDyne fund under 10b5-1 plan - Stock Titan

688K Dyne Therapeutics (DYN) shares sold by ForDyne fund under 10b5-1 plan  Stock Titan

688K Dyne Therapeutics (DYN) shares sold by ForDyne fund under 10b5-1 plan - Stock Titan

Click here to get full coverage on [144] Dyne Therapeutics, Inc. SEC Filing - Stock Titan

[144] Dyne Therapeutics, Inc. SEC Filing  Stock Titan

[144] Dyne Therapeutics, Inc. SEC Filing - Stock Titan

Click here to get full coverage on Dyne Therapeutics (DYN) CCO completes small tax-driven share sale - Stock Titan

Dyne Therapeutics (DYN) CCO completes small tax-driven share sale  Stock Titan

Dyne Therapeutics (DYN) CCO completes small tax-driven share sale - Stock Titan

Click here to get full coverage on Jefferies Maintains Buy on Dyne Therapeutics (DYN) March 2026 - Meyka

Jefferies Maintains Buy on Dyne Therapeutics (DYN) March 2026  Meyka

Jefferies Maintains Buy on Dyne Therapeutics (DYN) March 2026 - Meyka

Click here to get full coverage on Dyne Therapeutics (DYN) CMO auto-sells shares to cover RSU tax obligations - Stock Titan

Dyne Therapeutics (DYN) CMO auto-sells shares to cover RSU tax obligations  Stock Titan

Dyne Therapeutics (DYN) CMO auto-sells shares to cover RSU tax obligations - Stock Titan

Click here to get full coverage on Ja'dyn Muldrow's Stat Leader Rankings - MaxPreps.com

Ja'dyn Muldrow's Stat Leader Rankings  MaxPreps.com

Ja'dyn Muldrow's Stat Leader Rankings - MaxPreps.com

Click here to get full coverage on Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - Yahoo Finance

Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger  Yahoo Finance

Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - Yahoo Finance

Click here to get full coverage on [Form 4] Dyne Therapeutics, Inc. Insider Trading Activity - Stock Titan

[Form 4] Dyne Therapeutics, Inc. Insider Trading Activity  Stock Titan

[Form 4] Dyne Therapeutics, Inc. Insider Trading Activity - Stock Titan

Click here to get full coverage on Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN) - Yahoo Finance

Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN)  Yahoo Finance

Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN) - Yahoo Finance

Click here to get full coverage on Assessing Dyne Therapeutics (DYN) Valuation Following Recent Share Price Rally - Yahoo Finance

Assessing Dyne Therapeutics (DYN) Valuation Following Recent Share Price Rally  Yahoo Finance

Assessing Dyne Therapeutics (DYN) Valuation Following Recent Share Price Rally - Yahoo Finance

Click here to get full coverage on WINTON GROUP Ltd Makes New Investment in Dyne Therapeutics, Inc. $DYN - MarketBeat

WINTON GROUP Ltd Makes New Investment in Dyne Therapeutics, Inc. $DYN  MarketBeat

WINTON GROUP Ltd Makes New Investment in Dyne Therapeutics, Inc. $DYN - MarketBeat

Click here to get full coverage on Brian Posner Purchases 3,000 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock - MarketBeat

Brian Posner Purchases 3,000 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock  MarketBeat

Brian Posner Purchases 3,000 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock - MarketBeat

Click here to get full coverage on Dyne DMD trial shows better breathing, heart health after 24 months - Stock Titan

Dyne DMD trial shows better breathing, heart health after 24 months  Stock Titan

Dyne DMD trial shows better breathing, heart health after 24 months - Stock Titan

Click here to get full coverage on DYN - Dyne Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

DYN - Dyne Therapeutics, Inc. Latest Stock News & Market Updates  Stock Titan

DYN - Dyne Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Dyne Therapeutics (DYN) Receives Analyst Rating Update from Char - GuruFocus

Dyne Therapeutics (DYN) Receives Analyst Rating Update from Char  GuruFocus

Dyne Therapeutics (DYN) Receives Analyst Rating Update from Char - GuruFocus

Click here to get full coverage on Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry - Yahoo Finance

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry  Yahoo Finance

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry - Yahoo Finance

Click here to get full coverage on Dyne Therapeutics (DYN) Receives a Buy from Guggenheim - The Globe and Mail

Dyne Therapeutics (DYN) Receives a Buy from Guggenheim  The Globe and Mail

Dyne Therapeutics (DYN) Receives a Buy from Guggenheim - The Globe and Mail

Click here to get full coverage on DYN: Strong cash reserves and clinical progress position for key regulatory filings in 2026 - TradingView

DYN: Strong cash reserves and clinical progress position for key regulatory filings in 2026  TradingView

DYN: Strong cash reserves and clinical progress position for key regulatory filings in 2026 - TradingView

Click here to get full coverage on Dyne Therapeutics DMD And DM1 Progress Sharpens Rare Disease Investment Case - simplywall.st

Dyne Therapeutics DMD And DM1 Progress Sharpens Rare Disease Investment Case  simplywall.st

Dyne Therapeutics DMD And DM1 Progress Sharpens Rare Disease Investment Case - simplywall.st

Click here to get full coverage on Overweight Maintained for Dyne Therapeutics (DYN) by Morgan Stanley March 2026 - Meyka

Overweight Maintained for Dyne Therapeutics (DYN) by Morgan Stanley March 2026  Meyka

Overweight Maintained for Dyne Therapeutics (DYN) by Morgan Stanley March 2026 - Meyka

Click here to get full coverage on Lifesci Capital Brokers Raise Earnings Estimates for DYN - MarketBeat

Lifesci Capital Brokers Raise Earnings Estimates for DYN  MarketBeat

Lifesci Capital Brokers Raise Earnings Estimates for DYN - MarketBeat

Click here to get full coverage on Dyne Therapeutics (Nasdaq: DYN) reports 5.46% dystrophin gain, targets Q2 2026 FDA filing - Stock Titan

Dyne Therapeutics (Nasdaq: DYN) reports 5.46% dystrophin gain, targets Q2 2026 FDA filing  Stock Titan

Dyne Therapeutics (Nasdaq: DYN) reports 5.46% dystrophin gain, targets Q2 2026 FDA filing - Stock Titan

Click here to get full coverage on Dyne Therapeutics (NASDAQ:DYN) Trading 11.2% Higher - Time to Buy? - MarketBeat

Dyne Therapeutics (NASDAQ:DYN) Trading 11.2% Higher - Time to Buy?  MarketBeat

Dyne Therapeutics (NASDAQ:DYN) Trading 11.2% Higher - Time to Buy? - MarketBeat

Click here to get full coverage on What date does Dyne Therapeutics's (DYN) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

What date does Dyne Therapeutics's (DYN) report Earnings - Earnings Calendar & Announcement  Zacks Investment Research

What date does Dyne Therapeutics's (DYN) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

Click here to get full coverage on Q1 Earnings Estimate for DYN Issued By HC Wainwright - MarketBeat

Q1 Earnings Estimate for DYN Issued By HC Wainwright  MarketBeat

Q1 Earnings Estimate for DYN Issued By HC Wainwright - MarketBeat

Click here to get full coverage on Rare disease veteran joins biotech board before possible 2027 launch - Stock Titan

Rare disease veteran joins biotech board before possible 2027 launch  Stock Titan

Rare disease veteran joins biotech board before possible 2027 launch - Stock Titan

Click here to get full coverage on $DYN stock is up 41% today. Here's what we see in our data. - Quiver Quantitative

$DYN stock is up 41% today. Here's what we see in our data.  Quiver Quantitative

$DYN stock is up 41% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on WTT in new US FanDuel deal, extends with Dyn in Germany - Sportcal

WTT in new US FanDuel deal, extends with Dyn in Germany  Sportcal

WTT in new US FanDuel deal, extends with Dyn in Germany - Sportcal

Click here to get full coverage on Cooler Master Brings Dyn-X Racing Simulators to the Rolex 24 at Daytona - Morningstar

Cooler Master Brings Dyn-X Racing Simulators to the Rolex 24 at Daytona  Morningstar

Cooler Master Brings Dyn-X Racing Simulators to the Rolex 24 at Daytona - Morningstar

Click here to get full coverage on Analysts Have Conflicting Sentiments on These Healthcare Companies: Dyne Therapeutics (DYN), Biohaven Ltd. (BHVN) and Teladoc (TDOC) - The Globe and Mail

Analysts Have Conflicting Sentiments on These Healthcare Companies: Dyne Therapeutics (DYN), Biohaven Ltd. (BHVN) and Teladoc (TDOC)  The Globe and Mail

Analysts Have Conflicting Sentiments on These Healthcare Companies: Dyne Therapeutics (DYN), Biohaven Ltd. (BHVN) and Teladoc (TDOC) - The Globe and Mail

Click here to get full coverage on Handball Bundesliga taps Dyn to upgrade streaming service - Sportcal

Handball Bundesliga taps Dyn to upgrade streaming service  Sportcal

Handball Bundesliga taps Dyn to upgrade streaming service - Sportcal

Click here to get full coverage on Alcorn's Sound of Dyn-O-Mite to represent Mississippi in the 2025 Macy’s Thanksgiving Day Parade - Magnolia Tribune

Alcorn's Sound of Dyn-O-Mite to represent Mississippi in the 2025 Macy’s Thanksgiving Day Parade  Magnolia Tribune

Alcorn's Sound of Dyn-O-Mite to represent Mississippi in the 2025 Macy’s Thanksgiving Day Parade - Magnolia Tribune

Click here to get full coverage on Help send off Alcorn’s Sounds of Dyn‑O‑Mite to the Macy’s Thanksgiving Day Parade - WAPT

Help send off Alcorn’s Sounds of Dyn‑O‑Mite to the Macy’s Thanksgiving Day Parade  WAPT

Help send off Alcorn’s Sounds of Dyn‑O‑Mite to the Macy’s Thanksgiving Day Parade - WAPT

Click here to get full coverage on Potential Ohio State LB flip target Ja'Dyn Williams impresses James Laurinaitis with fast start to season - 247Sports

Potential Ohio State LB flip target Ja'Dyn Williams impresses James Laurinaitis with fast start to season  247Sports

Potential Ohio State LB flip target Ja'Dyn Williams impresses James Laurinaitis with fast start to season - 247Sports

Click here to get full coverage on Chardan Capital Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN) - MarketBeat

Chardan Capital Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN)  MarketBeat

Chardan Capital Reiterates "Buy" Rating for Dyne Therapeutics (NASDAQ:DYN) - MarketBeat

Click here to get full coverage on Should I buy Dyne Therapeutics (DYN) - Zacks Investment Research

Should I buy Dyne Therapeutics (DYN)  Zacks Investment Research

Should I buy Dyne Therapeutics (DYN) - Zacks Investment Research

Click here to get full coverage on Dyne Therapeutics (NASDAQ: DYN) pairs 2025 loss with pivotal DMD and DM1 milestones - Stock Titan

Dyne Therapeutics (NASDAQ: DYN) pairs 2025 loss with pivotal DMD and DM1 milestones  Stock Titan

Dyne Therapeutics (NASDAQ: DYN) pairs 2025 loss with pivotal DMD and DM1 milestones - Stock Titan

Click here to get full coverage on Dyne Therapeutics (DYN) Is Up 7.7% After DELIVER Trial Success and Accelerated Approval Plan – Has The Bull Case Changed? - Yahoo Finance

Dyne Therapeutics (DYN) Is Up 7.7% After DELIVER Trial Success and Accelerated Approval Plan – Has The Bull Case Changed?  Yahoo Finance

Dyne Therapeutics (DYN) Is Up 7.7% After DELIVER Trial Success and Accelerated Approval Plan – Has The Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Dyne Therapeutics, Inc. $DYN Holdings Raised by JPMorgan Chase & Co. - MarketBeat

Dyne Therapeutics, Inc. $DYN Holdings Raised by JPMorgan Chase & Co.  MarketBeat

Dyne Therapeutics, Inc. $DYN Holdings Raised by JPMorgan Chase & Co. - MarketBeat

Click here to get full coverage on Alcorn’s Sound of Dyn-O-Mite to represent Mississippi in the 2025 Macy’s Thanksgiving Day Parade - tallahatchienews.ms

Alcorn’s Sound of Dyn-O-Mite to represent Mississippi in the 2025 Macy’s Thanksgiving Day Parade  tallahatchienews.ms

DYN

Price Chart

Key Statistics

Technicals

About DYN

Latest News

Dynamax Regice Max Monday: Event Guide - Pokémon GO Hub

Dyne Therapeutics, Inc. $DYN Shares Bought by JPMorgan Chase & Co. - MarketBeat

Evan Van Dyn Hoven - Wisconsin Badgers

Advanced Charts

Top Gainers

Top Losers